WorldCat Identities

Belhassen, Manon

Overview
Works: 5 works in 5 publications in 1 language and 9 library holdings
Roles: Author, Other
Classifications: R729.5.G4, 616.7
Publication Timeline
.
Most widely held works by Manon Belhassen
Impact of bisphosphonate compliance on the risk of osteoporotic fracture in France by Manon Belhassen( )

1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide

Prescribed therapy for asthma: therapeutic ratios and outcomes by Laurent Laforest( )

1 edition published in 2016 in English and held by 2 WorldCat member libraries worldwide

Erratum to: Prescribed therapy for asthma: therapeutic ratios and outcomes by Laurent Laforest( )

1 edition published in 2016 in English and held by 2 WorldCat member libraries worldwide

Effectiveness of Montelukast on asthma control in infants: methodology of a French claims data study by Manon Belhassen( )

1 edition published in 2015 in English and held by 2 WorldCat member libraries worldwide

Recurrent Wheezing in Infants( )

1 edition published in 2016 in English and held by 1 WorldCat member library worldwide

Abstract : Abstract: Recurrent wheezing (RW) has a significant impact on infants, caregivers, and society, but morbidity and related medical resource utilization (MRU) have not been thoroughly explored. The burden of RW needs to be documented with population-based data. The objective was to assess the characteristics, medical management, and MRU of RW infants identified from national claims data. Infants aged from 6 to 24 months, receiving ≥2 dispensations of respiratory drugs within 3 months, and presenting a marker of poor control (index date), were selected. During the 6 months after index date, MRU was described in the cohort and among 3 subgroups with more severe RW, defined as ≥4 dispensations of respiratory drugs, ≥3 dispensations of oral corticosteroids (OCS), or ≥1 hospitalization for respiratory symptoms. A total of 115, 489 infants had RW, corresponding to 8.2% of subjects in this age group. During follow-up, 68.7% of infants received inhaled corticosteroids, but only 1.8 U (unit) were dispensed over 6 months, suggesting discontinuous use. Control was mostly inadequate: 61.7% of subjects received OCS, 80.2% antibiotics, and 71.2% short-acting beta-agonists, and medical/paramedical visits were numerous, particularly for physiotherapy. Severe RW concerned 39.0% of the cohort; 32.8% and 11.7% of infants had repeated use of respiratory drugs and OCS, respectively, and 5.5% were hospitalized for respiratory symptoms. In this real-life nation-wide study, RW was common and infants had poor control and high MRU. Interventions are needed to support adequate use of controller therapy, and to improve medical care
 
Audience Level
0
Audience Level
1
  General Special  
Audience level: 0.00 (from 0.00 for Effectiven ... to 0.00 for Effectiven ...)

Languages